These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 16801165)
21. Occult macrophage activation syndrome in systemic-onset juvenile idiopathic arthritic syndrome--a case report. Zeng P; Li F; Zeng H Acta Reumatol Port; 2013; 38(3):196-200. PubMed ID: 24149017 [TBL] [Abstract][Full Text] [Related]
22. Macrophage activation syndrome associated with griscelli syndrome type 2: case report and review of literature. Sefsafi Z; Hasbaoui BE; Kili A; Agadr A; Khattab M Pan Afr Med J; 2018; 29():75. PubMed ID: 29875956 [TBL] [Abstract][Full Text] [Related]
23. Does red-man reaction stimulate macrophage activation syndrome in children with systemic juvenile idiopathic arthritis? Olgar S; Ertugrul T; Devecioglu O; Nisli K; Omeroglu RE J Rheumatol; 2007 Dec; 34(12):2491-4. PubMed ID: 18061966 [TBL] [Abstract][Full Text] [Related]
24. Etanercept in the treatment of macrophage activation syndrome. Prahalad S; Bove KE; Dickens D; Lovell DJ; Grom AA J Rheumatol; 2001 Sep; 28(9):2120-4. PubMed ID: 11550985 [TBL] [Abstract][Full Text] [Related]
25. Favorable outcome in patients with renal involvement complicating macrophage activation syndrome in systemic onset juvenile rheumatoid arthritis. Ramanan AV; Rosenblum ND; Feldman BM; Laxer RM; Schneider R J Rheumatol; 2004 Oct; 31(10):2068-70. PubMed ID: 15468377 [TBL] [Abstract][Full Text] [Related]
35. Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-γ. Put K; Avau A; Brisse E; Mitera T; Put S; Proost P; Bader-Meunier B; Westhovens R; Van den Eynde BJ; Orabona C; Fallarino F; De Somer L; Tousseyn T; Quartier P; Wouters C; Matthys P Rheumatology (Oxford); 2015 Aug; 54(8):1507-17. PubMed ID: 25767156 [TBL] [Abstract][Full Text] [Related]
36. Characteristic elevation of soluble TNF receptor II : I ratio in macrophage activation syndrome with systemic juvenile idiopathic arthritis. Shimizu M; Inoue N; Mizuta M; Nakagishi Y; Yachie A Clin Exp Immunol; 2018 Mar; 191(3):349-355. PubMed ID: 28815559 [TBL] [Abstract][Full Text] [Related]
39. Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type. Quartier P; Taupin P; Bourdeaut F; Lemelle I; Pillet P; Bost M; Sibilia J; Koné-Paut I; Gandon-Laloum S; LeBideau M; Bader-Meunier B; Mouy R; Debré M; Landais P; Prieur AM Arthritis Rheum; 2003 Apr; 48(4):1093-101. PubMed ID: 12687553 [TBL] [Abstract][Full Text] [Related]